Zobrazeno 1 - 4
of 4
pro vyhledávání: '"José L Alonso-Romero"'
Autor:
Silvia Antolin Novoa, César A Rodríguez, Josefina Cruz, Sara López-Tarruella, Ariadna Tibau, Encarna Adrover, Ana Miguel, Mireia Margelí, Purificación Martínez, María Hernández, Antonio Antón, Álvaro Rodríguez-Lescure, Catalina Falo, Isabel Álvarez, Diego Malón, Raquel Andrés, José L Alonso-Romero, César Gómez, J. José Illaramendi, Ruth Campo, Juan José Miralles, Susana Bezares, Federico Rojo, Angel Guerrero-Zotano
Publikováno v:
Cancer Research. 83:P4-07
Background: Triple negative breast cancer (TNBC) is well known for its more aggressive course and poorer prognosis compared to other BC subtypes. RegistEM study provides real world data to understand the distribution of BC subtypes in the advanced se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd263d24bc1ba75ed50aca54c245b128
https://doi.org/10.1158/1538-7445.sabcs22-p4-07-45
https://doi.org/10.1158/1538-7445.sabcs22-p4-07-45
Autor:
Miguel Martín, Christoph Zielinski, Manuel Ruiz-Borrego, Eva Carrasco, Eva M. Ciruelos, Montserrat Muñoz, Begoña Bermejo, Mireia Margelí, Tibor Csöszi, Antonio Antón, Nicholas Turner, María I. Casas, Serafín Morales, Emilio Alba, Lourdes Calvo, Juan de la Haba-Rodríguez, Manuel Ramos, Laura Murillo, Ana Santaballa, José L. Alonso-Romero, Pedro Sánchez-Rovira, Massimo Corsaro, Xin Huang, Christiane Thallinger, Zsuzsanna Kahan, Miguel Gil-Gil
Publikováno v:
European journal of cancer (Oxford, England : 1990)
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
European Journal of Cancer
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
European Journal of Cancer
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
BACKGROUND: An earlier analysis of the PEARL phase III study showed that palbociclib plus endocrine therapy (ET) does not improve progression-free survival (PFS) over capecitabine in aromatase inhibitor-resistant, hormone receptor-positive/human epid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bec41fc0e5b09900e1831f4298f4b509
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=16586
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=16586
Autor:
Manuel Ruiz Borrego, Pablo Tolosa, Salvador Blanch, Adela Fernández, Ander Urriticoechea, Isabel Blancas, Cristina Saura, Beatriz Rojas, Begoña Bermejo, Jose Ponce, Maria Gión, Elisenda Llabres, Elena Galve, Juan Fernando Cueva, Ana López, José L Alonso-Romero, Santiago González-Santiago, Eduardo Martínez De Dueñas, Fernando Gomez Peralta, Eva Ciruelos, José Manuel Pérez-García, Antonio Llombart-Cussac, Javier Cortés
Publikováno v:
Cancer Research. 83:PD8-02
Background: HG is an on-target AE of PI3K inhibition, reported in 63.7% (36.6% G≥3) of HR[+]/HER2[-] ABC patients (pts) treated with ALP plus fulvestrant in SOLAR-1. HG was the most frequent adverse event (AE) leading to ALP discontinuation (6.3%).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93acc6f818c8c345c8bec8a33e2d219f
https://doi.org/10.1158/1538-7445.sabcs22-pd8-02
https://doi.org/10.1158/1538-7445.sabcs22-pd8-02
Autor:
José L Alonso-Romero
Publikováno v:
World Journal of Obstetrics and Gynecology. 2:21
Primary systemic treatment is a fundamental part of breast cancer therapy, and it is applied to non-surgical and locally advanced tumours as well as surgical tumours to increase the likelihood of conservative treatment. Its aim is to achieve the best
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14e7d6b0e1093ffce966bf46567c49b7
https://doi.org/10.5317/wjog.v2.i2.21
https://doi.org/10.5317/wjog.v2.i2.21